The global Long Acting Drug Delivery market size was valued at US$ 1758 million in 2024 and is forecast to a readjusted size of USD 2590 million by 2031 with a CAGR of 5.8% during review period.
Long acting drug delivery systems involve slow absorption of a drug containing active pharmaceutical ingredients, which are released into the system over subsequent time. The role of long acting drug delivery systems is clinically and medically beneficial for the treatment of chronic diseases and chronic pain, as well as certain neurological disorders. Long acting drug delivery systems include injectables, implants, microarrays or micro needle patches and broadly neutralizing monoclonal antibodies. The demand of long acting drug delivery systems is largely based on their high efficiency and targeted method of drug delivery.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Long Acting Drug Delivery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long Acting Drug Delivery market size and forecasts, in consumption value ($ Million), 2020-2031
Global Long Acting Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Long Acting Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Long Acting Drug Delivery market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long Acting Drug Delivery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long Acting Drug Delivery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Halozyme Therapeutics, Lubrizol Life Science, Celanese Corporation, Kashiv BioSciences, 4P Therapeutics, Ipsen, Midatech Pharma, Re-Vana Therapeutics, Creative Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Long Acting Drug Delivery market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Device
Parenteral Injections
Market segment by Application
Hospital
Specialty Clinics
Clinical Research Institutes
Others
Market segment by players, this report covers
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Long Acting Drug Delivery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long Acting Drug Delivery, with revenue, gross margin, and global market share of Long Acting Drug Delivery from 2020 to 2025.
Chapter 3, the Long Acting Drug Delivery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Long Acting Drug Delivery market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long Acting Drug Delivery.
Chapter 13, to describe Long Acting Drug Delivery research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long Acting Drug Delivery by Type
1.3.1 Overview: Global Long Acting Drug Delivery Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Long Acting Drug Delivery Consumption Value Market Share by Type in 2024
1.3.3 Device
1.3.4 Parenteral Injections
1.4 Global Long Acting Drug Delivery Market by Application
1.4.1 Overview: Global Long Acting Drug Delivery Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Specialty Clinics
1.4.4 Clinical Research Institutes
1.4.5 Others
1.5 Global Long Acting Drug Delivery Market Size & Forecast
1.6 Global Long Acting Drug Delivery Market Size and Forecast by Region
1.6.1 Global Long Acting Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Long Acting Drug Delivery Market Size by Region, (2020-2031)
1.6.3 North America Long Acting Drug Delivery Market Size and Prospect (2020-2031)
1.6.4 Europe Long Acting Drug Delivery Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Long Acting Drug Delivery Market Size and Prospect (2020-2031)
1.6.6 South America Long Acting Drug Delivery Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Long Acting Drug Delivery Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare Long Acting Drug Delivery Product and Solutions
2.1.4 ViiV Healthcare Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ViiV Healthcare Recent Developments and Future Plans
2.2 Halozyme Therapeutics
2.2.1 Halozyme Therapeutics Details
2.2.2 Halozyme Therapeutics Major Business
2.2.3 Halozyme Therapeutics Long Acting Drug Delivery Product and Solutions
2.2.4 Halozyme Therapeutics Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Halozyme Therapeutics Recent Developments and Future Plans
2.3 Lubrizol Life Science
2.3.1 Lubrizol Life Science Details
2.3.2 Lubrizol Life Science Major Business
2.3.3 Lubrizol Life Science Long Acting Drug Delivery Product and Solutions
2.3.4 Lubrizol Life Science Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Lubrizol Life Science Recent Developments and Future Plans
2.4 Celanese Corporation
2.4.1 Celanese Corporation Details
2.4.2 Celanese Corporation Major Business
2.4.3 Celanese Corporation Long Acting Drug Delivery Product and Solutions
2.4.4 Celanese Corporation Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Celanese Corporation Recent Developments and Future Plans
2.5 Kashiv BioSciences
2.5.1 Kashiv BioSciences Details
2.5.2 Kashiv BioSciences Major Business
2.5.3 Kashiv BioSciences Long Acting Drug Delivery Product and Solutions
2.5.4 Kashiv BioSciences Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Kashiv BioSciences Recent Developments and Future Plans
2.6 4P Therapeutics
2.6.1 4P Therapeutics Details
2.6.2 4P Therapeutics Major Business
2.6.3 4P Therapeutics Long Acting Drug Delivery Product and Solutions
2.6.4 4P Therapeutics Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 4P Therapeutics Recent Developments and Future Plans
2.7 Ipsen
2.7.1 Ipsen Details
2.7.2 Ipsen Major Business
2.7.3 Ipsen Long Acting Drug Delivery Product and Solutions
2.7.4 Ipsen Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Ipsen Recent Developments and Future Plans
2.8 Midatech Pharma
2.8.1 Midatech Pharma Details
2.8.2 Midatech Pharma Major Business
2.8.3 Midatech Pharma Long Acting Drug Delivery Product and Solutions
2.8.4 Midatech Pharma Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Midatech Pharma Recent Developments and Future Plans
2.9 Re-Vana Therapeutics
2.9.1 Re-Vana Therapeutics Details
2.9.2 Re-Vana Therapeutics Major Business
2.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Product and Solutions
2.9.4 Re-Vana Therapeutics Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Re-Vana Therapeutics Recent Developments and Future Plans
2.10 Creative Biolabs
2.10.1 Creative Biolabs Details
2.10.2 Creative Biolabs Major Business
2.10.3 Creative Biolabs Long Acting Drug Delivery Product and Solutions
2.10.4 Creative Biolabs Long Acting Drug Delivery Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Creative Biolabs Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Long Acting Drug Delivery Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Long Acting Drug Delivery by Company Revenue
3.2.2 Top 3 Long Acting Drug Delivery Players Market Share in 2024
3.2.3 Top 6 Long Acting Drug Delivery Players Market Share in 2024
3.3 Long Acting Drug Delivery Market: Overall Company Footprint Analysis
3.3.1 Long Acting Drug Delivery Market: Region Footprint
3.3.2 Long Acting Drug Delivery Market: Company Product Type Footprint
3.3.3 Long Acting Drug Delivery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Long Acting Drug Delivery Consumption Value and Market Share by Type (2020-2025)
4.2 Global Long Acting Drug Delivery Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Long Acting Drug Delivery Consumption Value Market Share by Application (2020-2025)
5.2 Global Long Acting Drug Delivery Market Forecast by Application (2026-2031)
6 North America
6.1 North America Long Acting Drug Delivery Consumption Value by Type (2020-2031)
6.2 North America Long Acting Drug Delivery Market Size by Application (2020-2031)
6.3 North America Long Acting Drug Delivery Market Size by Country
6.3.1 North America Long Acting Drug Delivery Consumption Value by Country (2020-2031)
6.3.2 United States Long Acting Drug Delivery Market Size and Forecast (2020-2031)
6.3.3 Canada Long Acting Drug Delivery Market Size and Forecast (2020-2031)
6.3.4 Mexico Long Acting Drug Delivery Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Long Acting Drug Delivery Consumption Value by Type (2020-2031)
7.2 Europe Long Acting Drug Delivery Consumption Value by Application (2020-2031)
7.3 Europe Long Acting Drug Delivery Market Size by Country
7.3.1 Europe Long Acting Drug Delivery Consumption Value by Country (2020-2031)
7.3.2 Germany Long Acting Drug Delivery Market Size and Forecast (2020-2031)
7.3.3 France Long Acting Drug Delivery Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Long Acting Drug Delivery Market Size and Forecast (2020-2031)
7.3.5 Russia Long Acting Drug Delivery Market Size and Forecast (2020-2031)
7.3.6 Italy Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Drug Delivery Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Long Acting Drug Delivery Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Long Acting Drug Delivery Consumption Value by Region (2020-2031)
8.3.2 China Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8.3.3 Japan Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8.3.4 South Korea Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8.3.5 India Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Long Acting Drug Delivery Market Size and Forecast (2020-2031)
8.3.7 Australia Long Acting Drug Delivery Market Size and Forecast (2020-2031)
9 South America
9.1 South America Long Acting Drug Delivery Consumption Value by Type (2020-2031)
9.2 South America Long Acting Drug Delivery Consumption Value by Application (2020-2031)
9.3 South America Long Acting Drug Delivery Market Size by Country
9.3.1 South America Long Acting Drug Delivery Consumption Value by Country (2020-2031)
9.3.2 Brazil Long Acting Drug Delivery Market Size and Forecast (2020-2031)
9.3.3 Argentina Long Acting Drug Delivery Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Drug Delivery Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Long Acting Drug Delivery Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Long Acting Drug Delivery Consumption Value by Country (2020-2031)
10.3.2 Turkey Long Acting Drug Delivery Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Long Acting Drug Delivery Market Size and Forecast (2020-2031)
10.3.4 UAE Long Acting Drug Delivery Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Long Acting Drug Delivery Market Drivers
11.2 Long Acting Drug Delivery Market Restraints
11.3 Long Acting Drug Delivery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Long Acting Drug Delivery Industry Chain
12.2 Long Acting Drug Delivery Upstream Analysis
12.3 Long Acting Drug Delivery Midstream Analysis
12.4 Long Acting Drug Delivery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
ViiV Healthcare
Halozyme Therapeutics
Lubrizol Life Science
Celanese Corporation
Kashiv BioSciences
4P Therapeutics
Ipsen
Midatech Pharma
Re-Vana Therapeutics
Creative Biolabs
听
听
*If Applicable.